WHAT TO KNOW ABOUT GLP-1 SHORTAGES — It’s been a busy week in the diabetes and weight-loss drug world as Eli Lilly renews its push to shut down the compounding of its tirzepatide products and the ...
Peptide companies' are creating knock-off versions of these drugs that have not been approved by the FDA and contain ...
Inventive deal structures are on the rise within China’s life sciences industry, with the “NewCo” model having garnered significant interest ...